Julie Bonner
Psychiatry · Palo Alto, CANPI 1790820942
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $212,990 of the $251,731 with a category attached, or 84.6%. 9 manufacturers reported payments, led by AbbVie at 57.7% of the total. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 369 payments — averaging $682.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$145K
- Teva Pharmaceuticals USA, Inc.$80K
- Axsome Therapeutics, Inc.$22K
- Sunovion Pharmaceuticals Inc.$4K
- Vanda Pharmaceuticals Inc.$269
- Otsuka America Pharmaceutical, Inc.$106
- plus $61 from 3 others
What the payments were for
- Consulting fees$4,5602%
- Speaking & faculty fees$212,99085%
- Travel & lodging$27,78811%
- Food & beverage$6,3013%
- Education$910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 220 | $145,123 |
| Teva Pharmaceuticals USA, Inc. | 94 | $80,192 |
| Axsome Therapeutics, Inc. | 27 | $22,104 |
| Sunovion Pharmaceuticals Inc. | 16 | $3,876 |
| Vanda Pharmaceuticals Inc. | 8 | $269 |
| Otsuka America Pharmaceutical, Inc. | 1 | $106 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $25 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$251,731 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clozapine | 11 | $1,079 |
| Quetiapine Fumarate | 25 | $70 |
| Lamotrigine | 17 | $55 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Palo Alto
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
- Konstantinos TripodisBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.